Clodronate appeared safe, modestly affected breast cancer disease events
Wednesday, December 7, 2011 - 16:31
in Health & Medicine
A recently presented study revealed that the bisphosphonate clodronate had a low incidence of adverse events and toxicity among patients with breast cancer and may modestly reduce the incidence of distant metastases in postmenopausal women.
